Thrivent Financial for Lutherans

Position in TGTX — Tg Therapeutics, Inc.

CIK 314984 Minneapolis, MN

Position in TGTX

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$3,014,781

+$229,782 QoQ

Shares Held

90,752

-2.9% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. TGTX ranks #16 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	1,568,627	$67,278,411
2	BMRN	Biomarin Pharmaceutical Inc	627,699	$35,458,716
3	VRTX	Vertex Pharmaceuticals Inc / Ma	75,977	$33,926,767
4	RPRX	Royalty Pharma plc	499,167	$23,945,040
5	TECH	BIO-TECHNE Corp	302,934	$15,831,330
6	ARGX	Argenx SE	12,682	$9,261,030
7	ALNY	Alnylam Pharmaceuticals, Inc.	20,470	$6,772,908
8	REGN	Regeneron Pharmaceuticals, Inc.	8,440	$6,521,080

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,014,781	90,752	-2.9%	Shares	Sole	2026-05-01
2025-12-31	$2,784,999	93,425	-4.6%	Shares	Sole	2026-02-05
2025-09-30	$3,536,131	97,886	-1.8%	Shares	Sole	2025-11-04
2025-06-30	$3,588,742	99,715	+1.7%	Shares	Sole	2025-08-26
2025-03-31	$3,865,638	98,038	-5.0%	Shares	Sole	2025-08-26
2024-12-31	$3,105,356	103,168	-1.5%	Shares	Sole	2025-02-10
2024-09-30	$2,450,429	104,764	+172.2%	Shares	Sole	2024-11-07
2024-03-31	$585,432	38,490	-31.5%	Shares	Sole	2024-05-14
2023-12-31	$960,236	56,220	-16.3%	Shares	Defined	2024-02-14
2023-09-30	$561,649	67,183	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.